NEWS AND INSIGHTS
RightHill Ventures Commits $1.5 Million to Slater-Backed Drug Discovery Company
New Fund Participates in Series A Financing for URI-Based MindImmune, Developer of a Novel Treatment for Neuroinflammatory Conditions Such as Alzheimer’s Disease
Slater Sushi & Networking: Starring this year’s B-Lab entrepreneurs
Join Slater, RightHill Ventures, and the Nelson Center for Entrepreneurship for a special summer sushi networking event celebrating the participants of the Nelson Center’s venture accelerator, the Breakthrough Lab (B-Lab).
Arctura Awarded $1.15 Million Grant from U.S. Dept. of Energy
Arctura has won a $1.15-million Phase IIB SBIR grant from the U.S. Department of Energy (DOE) to commercialize a new blade coating designed to reduce the damage to wind turbine blades caused by lightning.
Slater-Backed Company Acquired by Novartis
The Slater Technology Fund, Rhode Island’s oldest and most active seed-stage investment fund, applauds the team at Cadent Therapeutics, who today announced that the company has entered into an agreement to be acquired by global healthcare giant Novartis [NYSE: NVS] in a deal worth up to $770 million.
